Acinetobacter baumannii is a Gram-negative bacteria associated with hospital-acquired infections. Definitely, antimicrobial resistance and biofilm formation capabilities of clinical isolates have threading potential to persistence in the hospital environment and colonization on medical equipment. Twenty-seven multidrug-resistant clinical isolates were selected from a collection of A. baumannii samples isolated from clinical settings. PCR assays showed the frequencies of genes related to biofilm formation: ompA (100 %), bap (30 %) and blaPER-1 (44 %). Polyclonal antibodies against recombinant AbOmpA8–346 and Bap1–487 proteins were obtained by the mouse immunization method. Western blotting revealed all isolates expressed AbOmpA and only eight isolates were positive for Bap factor. Two strains that had their bap gene disrupted with ISAba125 did not express Bap protein. Our findings showed that all double-negative bap/blaPER-1 isolates were recovered from the bloodstream and had low biofim formation capabilities, and mostly belonged to type D wrinkled colony morphology. However, clinical isolates extracted from the throats of patients were blaPER-1-positive and had a great capacity to form biofilm, and also mostly belonged to type C wrinkled colony morphology.
BrossardKA, CampagnariAA. 2012; The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect Immun 80:228–233 doi: [View Article]
GaddyJA, TomarasAP, ActisLA. 2009; The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect Immun 77:3150–3160 doi: [View Article]
HamidianM, HancockDP, HallRM. 2013; Horizontal transfer of an ISAba125-activated ampC gene between Acinetobacter baumannii strains leading to cephalosporin resistance. J Antimicrob Chemother 68:244–245 doi: [View Article]
JungJY, ParkMS, KimSE, ParkBH, SonJY, KimEY, LimJE, LeeSK, LeeSH, other authors. 2010; Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis 10:228 doi: [View Article]
LeeJS, LeeJC, LeeCM, JungID, JeongYI, SeongEY, ChungHY, ParkYM. 2007; Outer membrane protein A of Acinetobacter baumannii induces differentiation of CD4+T cells toward a Th1 polarizing phenotype through the activation of dendritic cells. Biochem Pharmacol 74:86–97 doi: [View Article]
McConnellMJ, PachónJ. 2011; Expression, purification, and refolding of biologically active Acinetobacter baumannii OmpA from Escherichia coli inclusion bodies. Protein Expr Purif 77:98–103 doi: [View Article]
MoffattJH, HarperM, AdlerB, NationRL, LiJ, BoyceJD. 2011; Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii
. Antimicrob Agents Chemother 55:3022–3024 doi: [View Article]
ObeidatN, JawdatF, Al-BakriAG, ShehabiAA. 2014; Major biologic characteristics of Acinetobacter baumannii isolates from hospital environmental and patients' respiratory tract sources. Am J Infect Control 42:401–404 doi: [View Article]
SechiLA, KaradenizliA, DeriuA, ZanettiS, KolayliF, BalikciE, VahabogluH. 2004; PER-1 type beta-lactamase production in Acinetobacter baumannii is related to cell adhesion. Med Sci Monit 10:BR180–BR184
ShahcheraghiF, AbbasalipourM, FeizabadiM, EbrahimipourG, AkbariN. 2011; Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol 3:68–74